Core Viewpoint - Beitaini's revenue and net profit have significantly declined in recent quarters, indicating pressure on its financial performance and the need for strategic adjustments in its product offerings and market positioning [3][5][6]. Financial Performance - In 2024, Beitaini's revenue growth rates were 3.87% and -13.51% for the first quarter, while net profit growth rates were -33.53% and -83.97% respectively [3][5]. - The company's net profit for 2024 dropped to 503 million yuan, less than half of the same period in 2022 [6]. - The overall performance in the first quarter of 2025 showed a revenue of 949 million yuan, a decline of 13.51%, and a net profit of 28 million yuan, marking an 84% decrease, the lowest since its listing [7]. Brand and Product Strategy - Beitaini focuses on the "skin health internet+" model, with multiple brands including Winona, Winona Baby, and AOXMED, targeting various skincare needs [5]. - The main brand, Winona, has undergone a brand upgrade to focus on "sensitive skin," launching key products like the Winona Soothing Moisturizing Cream [9]. - Despite the brand's efforts, Winona's revenue declined by 5.5% in 2024, contrasting with significant growth in its sub-brands Winona Baby and AOXMED, which saw increases of 34% and 65.6% respectively [9][10]. Market Position and Competition - Beitaini's performance in major promotional events has weakened, with Winona ranking 10th in the Tmall beauty sales during the 2024 promotional events, down from 5th in 2023 [9][11]. - The company faces increased competition and has had to raise marketing expenditures, impacting profitability [6][10]. Future Outlook - Beitaini plans to implement five core solutions for its main brand, focusing on enhancing customer value through product combinations [10]. - The company aims to leverage its advancements in plant-based ingredients and AI technology to regain market traction [9].

Group 1: Market Performance - Major indices experienced a rebound on June 4, with the Shanghai Composite Index rising by 0.42%, the Shenzhen Component Index by 0.87%, and the ChiNext Index by 1.11% [2] - Over 3,700 stocks in the Shanghai and Shenzhen markets saw gains, with a total trading volume of approximately 1.15 trillion yuan [2] Group 2: Beauty and Personal Care Sector - The beauty and personal care sector showed strong performance, with companies like Haoyue Care rising by 10% and Jinbo Biological by 7.36% [2] - A report from China Merchants Securities indicated that the cosmetics sector will continue to see performance differentiation in 2024 and Q1 2025, with leading domestic brands benefiting from competitive pricing and differentiated products [2] Group 3: AI and CPO Technology - Companies involved in AI and CPO technology saw significant gains, with Taicheng Light rising by 14.88% and Xinyi Sheng by over 7% [2][3] - Yole's report predicts that the CPO market will grow from $46 million in 2024 to $8.1 billion by 2030, with a compound annual growth rate of 137% [3] Group 4: Beer Industry - The beer sector also showed strength, with companies like Pinwo Food rising by 12.84% and Huichuan Beer by over 7% [3] - Analysts noted that the beer industry is in the late stage of capital expenditure, with potential for increased dividend payouts from state-owned enterprises [3] Group 5: Battery and Solid-State Battery Sector - The battery and solid-state battery sectors were active, with Keheng Co. rising by 20% and Nord Co. by 10% [4] - Solid-state batteries are expected to start vehicle verification by 2027 and achieve mass production by 2030, with projected shipments exceeding 65 GWh by that year [4] Group 6: Declining Sectors - The logistics and airport shipping sectors faced declines, with companies like China Eastern Airlines and Shentong Express experiencing downturns [5]

6月3日突破年线个股乖离率排名 | 证券代 | 证券简 | 今日涨跌幅 | 今日换手率 | 年线 | 最新价 | 乖离率 | | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （%） | （元） | （元） | （%） | | 300315 | 掌趣科 | 15.34 | 21.77 | 5.09 | 5.79 | 13.71 | | | 技 | | | | | | | 300629 | 新劲刚 | 13.29 | 15.51 | 19.53 | 22.00 | 12.66 | | 300957 | 贝泰妮 | 12.12 | 4.96 | 45.60 | 49.57 | 8.70 | | 600250 | 南京商 旅 | 9.97 | 10.45 | 8.76 | 9.49 | 8.32 | | 688793 | 倍轻松 | 5.25 | 3.94 | 31.12 | 32.66 | 4.96 | | 688105 | 诺唯赞 | 5.10 | 0.89 | 22.02 | 23.06 | 4.72 | | 300352 | 北信源 | ...

Core Viewpoint - The cosmetics retail sales in China for January to April 2025 showed a year-on-year increase of 4%, underperforming the overall retail market by 0.7 percentage points, but this represents an improvement compared to 2024. The industry is characterized by four key trends: innovation in personal care products, breakthroughs in ingredient technology, rising emotional consumption, and the continuation of affordable consumption [1][3]. Investment Recommendations - The company recommends increasing holdings in the personal care sector, highlighting quality companies that benefit from product innovation and opportunities in Douyin channels, with key recommendations including Ruoyuchen (003010), Dengkang Oral (001328), and Runben Co. [2] - In the beauty sector, structural opportunities are identified, with key recommendations for companies like Jinbo Biological, Juzi Biological, and Marubi Co. that are positioned to benefit from the collagen restructuring trend. Additionally, brands like Maogeping, Shumei Co., Proya (603605), and Shanghai Jahwa (600315) are expected to gain from the overall increase in domestic market share [2]. - Companies expected to bottom out and potentially see a turning point include Lafang Household (603630), Shuiyang Co. (300740), Betaini (300957), Furuida (600223), Huaxi Biological, Fulejia (301371), Meilitiantian Medical Health, and Qingsong Co. (300132) [2]. Industry Overview - Demand remains stable, with the rise of domestic brands in the beauty and personal care sectors accelerating. The cosmetics retail sales for January to April 2025 increased by 4% year-on-year, which is a 0.7 percentage point underperformance compared to the overall retail market, but shows improvement from 2024. The overall demand is stable, with leading domestic brands performing well and the rise of new domestic brands spreading from beauty to personal care categories [3][4]. Trends - The industry is witnessing several trends: 1) Personal care transformation with new products in traditional categories, supported by content e-commerce creating a favorable environment for new product launches [4]. 2) Ingredient innovation, particularly in collagen restructuring, with various types and structural innovations expanding application scenarios [4]. 3) Emotional consumption, where cultural, stylistic, and experiential demands are driving the growth of domestic trends in cosmetics and fragrances [4]. 4) Affordable consumption, where the trend for cost-effectiveness continues under supply-demand resonance, benefiting strong supply chains and well-operated brands [4]. Key Companies - Looking ahead to 2025, the market risk appetite is expected to recover significantly. The beauty sector is characterized by substantial changes and a clear trend of rising domestic brands, indicating strong growth potential and leadership in new consumption [5]. The differentiation among brands is increasing, emphasizing the selection of high-growth targets driven by product innovation and attention to marginal improvements [5].

Market Overview - The Shanghai Composite Index closed at 3363.48 points, above the five-day moving average, with an increase of 0.48% [1] - The total trading volume of A-shares reached 763.885 billion yuan [1] Stock Performance - A total of 929 A-shares broke through the five-day moving average today [1] - Stocks with significant deviation rates include: - Laisai Laser (21.79%) - Kangliyuan (11.86%) - Mankalon (10.78%) [1] Top Stocks by Deviation Rate - Laisai Laser (871263): - Today's change: +30.00% - Turnover rate: 38.87% - Five-day moving average: 19.53 yuan - Latest price: 23.79 yuan - Deviation rate: 21.79% [1] - Kangliyuan (301287): - Today's change: +17.32% - Turnover rate: 32.85% - Five-day moving average: 35.00 yuan - Latest price: 39.15 yuan - Deviation rate: 11.86% [1] - Mankalon (300945): - Today's change: +19.98% - Turnover rate: 18.47% - Five-day moving average: 22.66 yuan - Latest price: 25.10 yuan - Deviation rate: 10.78% [1] Additional Notable Stocks - Beitaini (300957): - Today's change: +11.83% - Turnover rate: 4.22% - Five-day moving average: 45.58 yuan - Latest price: 49.44 yuan - Deviation rate: 8.48% [1] - Jiuling Technology (873305): - Today's change: +10.00% - Turnover rate: 13.81% - Five-day moving average: 42.79 yuan - Latest price: 46.20 yuan - Deviation rate: 7.98% [1]

Market Overview - The Shanghai Composite Index closed at 3363.48 points, above the annual line, with a change of 0.48% [1] - The total trading volume of A-shares reached 763.885 billion yuan [1] Stocks Breaking Annual Line - A total of 75 A-shares have surpassed the annual line today, with notable stocks including: - Zhangqu Technology (掌趣科技) with a deviation rate of 11.95% - New Jingang (新劲刚) at 8.64% - Beitaini (贝泰妮) at 8.42% [1] Top Stocks by Deviation Rate - The following stocks have the highest deviation rates from the annual line: - Zhangqu Technology (掌趣科技): Today's change of 13.55%, turnover rate of 20.26%, annual line at 5.09 yuan, latest price at 5.70 yuan [1] - New Jingang (新劲刚): Today's change of 9.22%, turnover rate of 12.15%, annual line at 19.52 yuan, latest price at 21.21 yuan [1] - Beitaini (贝泰妮): Today's change of 11.83%, turnover rate of 4.22%, annual line at 45.60 yuan, latest price at 49.44 yuan [1] Additional Stocks with Notable Performance - Other stocks with significant performance include: - Nanjing Shanglv (南京商旅): Change of 9.97%, turnover rate of 9.74%, annual line at 8.76 yuan, latest price at 9.49 yuan [1] - Beixin Source (北信源): Change of 6.31%, turnover rate of 7.33%, annual line at 4.99 yuan, latest price at 5.22 yuan [1] - Bolei Technology (倍轻松): Change of 3.67%, turnover rate of 3.40%, annual line at 31.11 yuan, latest price at 32.17 yuan [1]

Market Overview - The Shanghai Composite Index increased by 0.14% as of 10:28 AM, with a trading volume of 470.90 billion shares and a turnover of 564.58 billion yuan, a decrease of 4.56% compared to the previous trading day [1] Industry Performance - The top-performing industries included: - Beauty Care: Increased by 3.21% with a transaction amount of 60.32 billion yuan, up 14.82% from the previous day, led by Beitaini with a rise of 12.83% [1] - Comprehensive: Increased by 1.90% with a transaction amount of 13.55 billion yuan, up 3.98%, led by Zhangzhou Development with a rise of 4.98% [1] - Non-ferrous Metals: Increased by 1.68% with a transaction amount of 203.46 billion yuan, up 42.48%, led by Western Gold with a rise of 10.03% [1] - The worst-performing industries included: - Household Appliances: Decreased by 1.57% with a transaction amount of 86.91 billion yuan, up 13.63%, led by Gree Electric with a decline of 3.02% [2] - Steel: Decreased by 1.55% with a transaction amount of 28.09 billion yuan, up 41.91%, led by Benxi Steel with a decline of 7.23% [2] - Coal: Decreased by 1.17% with a transaction amount of 30.97 billion yuan, up 49.83%, led by China Coal Energy with a decline of 3.27% [2] Stock Performance - A total of 3,065 stocks rose, with 55 hitting the daily limit up, while 2,094 stocks fell, with 5 hitting the daily limit down [1]

Group 1 - The cosmetics sector is experiencing a rise, with Betaini (300957) increasing by over 10% [1] - Other companies such as Babi Co., Water Sheep Co. (300740), Fulejia (301371), Lafang Jiahua (603630), and Furida (600223) are also seeing gains [1]

Summary of the Conference Call Transcript Company Overview - **Company**: 贝泰妮 (Betaini) - **Industry**: Consumer Goods, specifically skincare and beauty products Key Points and Arguments 1. **Profitability Goals**: The company aims for a double-digit net profit margin by 2025, up from 8.8% in 2024, supported by a targeted 3% increase in gross margin, efficiency improvements, and operational leverage [1][4] 2. **Revenue Targets**: - Main brand, 薇诺娜 (Winona), is expected to achieve single-digit revenue growth, focusing on product reform and promotional control [1][4] - Emerging brands are projected to maintain growth momentum, with 薇诺娜宝贝 (Winona Baby) targeting over 30% growth, 瑗科缦 (Yuan Keman) over 100%, and 贝芙汀 (Beifutin) aiming for 50 million yuan [1][4] 3. **Quarterly Performance**: The second quarter shows improvement, with a strong start to the 6.18 shopping event, reporting a 20-30% increase in GMV through live streaming channels and a 30-40% increase on Douyin [1][4] 4. **Inventory Management**: Inventory balances improved, with figures of 556 million yuan and 612 million yuan for Q1 2025 and FY2024 respectively, down 34% and 32% from FY2023 [1][4] 5. **OTC Channel Expansion**: Sales in the OTC channel are recovering, with a projected 10% growth in sales for approximately 129,000 OTC pharmacies in 2024 [1][4] 6. **Financial Forecasts**: - Revenue is expected to grow from 5.736 billion yuan in FY24 to 6.196 billion yuan in FY25, with a compound annual growth rate (CAGR) of 10% from 2025 to 2027 [1][9] - Adjusted net profit is projected to increase from 503 million yuan in FY24 to 654 million yuan in FY25 [1][8] 7. **Market Position**: Winona is the largest efficacy skincare brand in China, holding a 20% market share, outperforming competitors like 理肤泉 (La Roche-Posay) and 修丽可 (SkinCeuticals) [1][9] 8. **Valuation**: The target price is set at 66 yuan, corresponding to a 35x 12-month forward P/E ratio, based on a discounted cash flow analysis [1][14] Additional Important Information - **Risks**: - Downside risks include potential failure in brand expansion, high traffic costs, intensified competition, and increased regulatory scrutiny on efficacy skincare advertising [1][16] - Upside catalysts include better-than-expected performance of new products and successful acquisitions [1][16] - **Stock Performance**: The stock price as of May 28, 2025, is 45.29 yuan, with a target price of 66.00 yuan by December 2025 [2][22] This summary encapsulates the essential insights from the conference call, highlighting the company's strategic direction, financial targets, market positioning, and associated risks.

Group 1: Brand Strategy - The brand Winona Baby will continue to focus on pediatric dermatology, specifically addressing infant eczema, and aims to provide comprehensive skincare solutions segmented by season, area, and age [3] - AOXMED will deepen its product matrix in 2025, targeting professional clinics and home care scenarios, with plans to launch new products based on anti-aging concepts [3] - The company has opened 179 new direct-operated stores by the end of last year, focusing on core business districts in first and second-tier cities [3] Group 2: Distribution Channels - As of last year, the OTC distribution channel has covered over 129,000 pharmacies nationwide [3] - The average transaction value on the OMO online sales platform exceeded RMB 1,500, demonstrating strong market penetration [3] Group 3: Technological Innovation - The company collaborates with 63 top-tier hospitals for clinical validation of Winona products, resulting in nearly 500 published academic papers and participation in the formulation of 68 group standards [4] - AI systems are utilized to enhance production speed and blockchain technology is employed to combat counterfeit products, ensuring consumer rights [4] - The company has established research centers in France and Japan and has received international innovation awards for its unique ingredients [4]